Concepedia

Hamza Hashmi

HH

Statistics

Publications

39

Citations

2K

H-Index

24

Active since

2016

Affiliations

Medical University of South Carolina(Current)

Moffitt Cancer Center

Cleveland Clinic

The University of Texas Southwestern Medical Center

University of Kansas Medical Center

Hamza Hashmi is an author at Medical University of South Carolina specializing in medicine, immunotherapy, and multiple myeloma.

Publications per year

2016–2025

39

Publications

39

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

Paul G. Richardson, Susanna Jacobus, Edie Weller et al. · New England Journal of Medicine · 2022 · 463 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

Doris K. Hansen, Surbhi Sidana, Lauren C. Peres et al. · Journal of Clinical Oncology · 2023 · 279 citations · Full text

Medicine, Immunology, Oncology +15

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi et al. · Blood Cancer Journal · 2023 · 111 citations · Full text

Medicine, Hematology, Oncology +17

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi et al. · Blood Advances · 2022 · 99 citations · Full text

Medicine, Hematology, Oncology +14

Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

Nico Gagelmann, Danai Dima, Maximilian Merz et al. · Journal of Clinical Oncology · 2024 · 83 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 39